Advertisement

Advertisement

Quick Chats

hematologic malignancies

By The ASCO Post Staff / Quick Chats

Andrew D. Zelenetz, MD, PhD, and Stephen J. Schuster, MD, on CAR T Cells for Hematologic Malignancies: Where We’re At

multiple myeloma

By The ASCO Post Staff / Quick Chats

Paul G. Richardson, MD, and Peter M. Voorhees, MD, on Multiple Myeloma: Surveying the Evolving Landscape of Up-Front Drugs

colorectal cancer

gastrointestinal cancer

By The ASCO Post Staff / Quick Chats

Heinz-Josef Lenz, MD, and Axel Grothey, MD, on Liquid Biopsies for Colorectal and Other GI Cancers

colorectal cancer

genomics/genetics

By The ASCO Post Staff / Quick Chats

Heinz-Josef Lenz, MD, and Axel Grothey, MD, on Colorectal Cancer: Molecular Testing and Interpreting an NGS Report

Advertisement

Advertisement

May

29

Today In Oncology

How Family Adventures, Precision Oncology, and Living Purposefully Bring Balance to the Life of Charu Aggarwal, MD, MPH, FASCO

Adaptive Manufactured Lentiviral Anti-CD20 Anti-CD19 CAR T Cells in Relapsed Refractory Mantle Cell Lymphoma

Alcohol May Be Linked to Higher Risk of Pancreatic Cancer

First-Line Nivolumab-Ipilimumab vs Lenvatinib or Sorafenib in Unresectable Hepatocellular Carcinoma

Physical Function Acts as Predictor of Survival for Daratumumab-Based Therapy in Multiple Myeloma

Advertisement

© 2025 HSP News Service, L.L.C.